Company Profile: HistoRx: tissue-based diagnostic solutions for personalized medicine. (March 2012)

• Record Type: Journal Article
• Authors: Dolled-Filhart, Marisa; Romeo, Elisa; Adams, Kathleen; Davis, Wendy; Gustavson, Mark
• Is Part Of: Personalized medicine. Volume 9:Number 2(2012)
• Page Start: 185
• Page End: 190
• Publication Date: 2012-03
• Subjects: Pharmacogenomics -- Periodicals; Pharmacogenetics -- Periodicals; 615.19
• DOI: 10.2217/pme.12.4
• Languages: English
• ISSNs: 1741-0541

Abstract

The mission of HistoRx (CT, USA) is to develop and commercialize clinically actionable immunohistochemical (IHC) biomarker assays with the distinctive characteristic of being as quantitative, objective and standardized as the measurement of glucose in blood. In clinical laboratory practice, serum glucose measurement is expected to give the same result regardless of the laboratory or operator performing the test, and the same should be true for tissue-based IHC tests in anatomical pathology. By offering such improvements to standard IHC analysis using reproducible AQUA ® assays, patients will benefit from standardized results for determination of appropriate targeted therapeutic drug treatment.